Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Joanna Elizabeth Cripps has worked on the following 16 EPO patent applications which have been published in the last five years:

EP11722941

METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF COMPOUNDS

IPC classification:
A61K 38/04, A61K 47/48, A61P 35/00
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Agent:
Michaela Elbel, pateris Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP11758012

ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT

IPC classification:
A61K 31/55, A61P 3/04
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12731142

MATERIALS AND METHODS FOR DETERMINING SENSITIVITY POTENTIAL OF COMPOUNDS

IPC classification:
C07K 14/00, G01N 33/50
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Agent:
Multiple attorneys, Proteome Sciences plc
Status:
GRANT OF PATENT INTENDED
EP12756810

MATERIALS AND METHODS FOR DETERMINING SENSITIVITY POTENTIAL OF COMPOUNDS

IPC classification:
G01N 33/50, G01N 33/68
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Agent:
Daniela Gill-Carey, Novartis Pharma AG
Agent:
Multiple attorneys, Proteome Sciences plc
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13705833

MATERIALS AND METHODS RELATING TO PACKAGING CELL LINES

IPC classification:
A61K 48/00, C12N 5/10, C12N 7/00, C12N 15/867
Applicant:
UCL Business plc
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12191625

Methods and compositions relating to Alzheimer's disease

IPC classification:
A61P 25/28, G01N 33/68
Applicant:
King's College London
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15169002

ADMINISTRATION OF LORCASERIN TO INDVIDUALS WITH RENAL IMPAIRMENT

IPC classification:
A61K 31/55, A61P 3/04
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13878220

A CRYSTALLINE FORM OF AN ANXIOLYTIC COMPOUND

IPC classification:
A61K 31/4375, A61P 25/16, A61P 25/22, A61P 25/24, A61P 25/28, C07D 487/04
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14765186

SALTS, CO-CRYSTALS, AND POLYMORPHS OF AN ANXIOLYTIC COMPOUND

IPC classification:
A61K 31/4375, A61P 25/00, A61P 25/04, A61P 25/20, A61P 25/22, A61P 25/24, A61P 25/28, C07D 417/04
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11787424

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF PRIMARY INSULIN-LIKE GROWTH FACTOR DEFICIENCY (PIGFD) AND IDIOPATHIC SHORT STATURE (ISS)

IPC classification:
C12Q 1/68
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14851064

COMPOSITIONS COMPRISING A DEFINED MICROBIOME AND METHODS OF USE THEREOF

IPC classification:
A61K 35/74
Applicant:
The Trustees of The University of Pennsylvania
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15731064

COMPOSITION AND USE THEREOF

IPC classification:
Applicant:
DuPont Nutrition Biosciences ApS
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15731062

ANIMAL FEED AND AQUAFEED

IPC classification:
Applicant:
DuPont Nutrition Biosciences ApS
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15731063

COMPOSITION AND USE THEREOF

IPC classification:
Applicant:
DuPont Nutrition Biosciences ApS
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15818144

METHODS AND COMPOSITIONS TO MODULATE HAIR GROWTH

IPC classification:
A61P 17/14, C12N 5/071, C12N 5/0797, G01N 33/50
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15843174

ANTI-ENDOTHELIAL LIPASE COMPOUNDS AND METHODS OF USING THE SAME IN THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR DISEASES

IPC classification:
C07D 405/12
Agent:
Joanna Elizabeth Cripps, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature